19 unknown. 19 Phase 2, 10 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 19 | Unknown 19 |
| Phase 1 | 10 | Unknown 10 |
| Phase 3 | 1 | Unknown 1 |
Follow Alopecia: new trials by email Literature Review of Alopecia trials Research Report on Alopecia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of Latanoprost Combined With Fractional Erbium- YAG Laser Latanoprost - Alopecia Areata | Phase 1 / Phase 2 | Unknown | Egymedicalpedia | 70 | 2024-02-01 | 2024-04-16 |
| Efficacy and Safety of Topical Vitamin D Analogue in Treatment of Female Pattern Hair Loss Topical minoxidil, Topical Vitamin D, Saline spray - Dermatology, Female Pattern Baldness | Phase 1 / Phase 2 | Unknown | Sohag University | 45 | 2023-05-20 | 2024-03-27 |
| Effectiveness and Safety of Topical Finasteride and Minoxidil Combination Compared to Topical Minoxidil for The Treatment of Male Androgenetic Alopecia Finasteride, Minoxidil - Androgenetic Alopecia | Phase 2 / Phase 3 | Unknown | Universitas Indonesia | 40 | 2023-05-01 | 2023-09-22 |
| Investigate the Efficacy and Safety of Farudodstat Compared With Its Placebo in Adult Alopecia Areata Participants Farudodstat, Placebo - Alopecia Areata | Phase 2 | Unknown | ASLAN Pharmaceuticals | 60 | 2023-04-14 | 2023-12-18 |
| Treatment of Alopecia Using Follicular Stem Cells Follicular stem cells, Standard treatment according to the clinical protocols - Alopecia | Phase 1 / Phase 2 | Unknown | Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus | 30 | 2022-03-01 | 2022-01-27 |
| A Study to Evaluate the Efficacy and Safety of Rosnilimab (ANB030) in Treatment of Subjects With Moderate-to-Severe Alopecia Areata Rosnilimab, Placebo - Alopecia Areata | Phase 2 | Unknown | AnaptysBio, Inc. | 45 | 2021-12-22 | 2022-05-10 |
| Intralesional Vitamin D in Alopecia Areata triamcinolone acetonide, vitamin D - Alopecia Areata | Phase 1 / Phase 2 | Unknown | Alexandria University | 40 | 2021-11-01 | 2021-07-26 |
| A Study With Jaktinib Hydrochloride Cream Applied Topically to Subjects With Alopecia Areata Jaktinib hydrochloride cream, Placebo - Alopecia Areata(AA) | Phase 1 / Phase 2 | Unknown | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 160 | 2020-08-12 | 2024-03-06 |
| Safety and Efficacy Study of SHAPE Gel in Alopecia Areata SHAPE Gel - Alopecia Areata | Phase 2 | Unknown | TetraLogic Pharmaceuticals | 40 | 2017-02-01 | 2016-10-20 |
| Treatment of Androgenetic Alopecia in Males With Theradome™ LH80 PRO LH80 PRO, Sham Device - Androgenetic Alopecia | Phase 2 | Unknown | Theradome, Inc. | 80 | 2015-08-01 | 2016-12-02 |
| Excimer Light for Alopecia Areata UVB excimer light - Alopecia Areata | Phase 2 | Unknown | University of British Columbia | 18 | 2013-02-01 | 2015-07-02 |
| Stem Cell Educator Therapy in Alopecia Areata Stem Cell Educator - Alopecia Areata | Phase 1 / Phase 2 | Unknown | Throne Biotechnologies Inc. | 30 | 2012-08-01 | 2012-08-28 |
| A Study to Determine the Safety and Efficacy of Autologous Human Platelet Lysate for Treatment of Androgenetic Alopecia Autologous Human Platelet Lysate (HPL), 2 % Minoxidil and /or Finasteride - Androgenetic Alopecia | Phase 1 / Phase 2 | Unknown | Kasiak Research Pvt. Ltd. | 20 | 2012-01-01 | 2012-07-25 |
| Study To Determine Safety & Efficacy Of Autologous Human Platelet Lysate in Androgenetic Alopecia After Hair Transplant Autologous Human Platelet Lysate, Standard hair follicle transplant - Androgenetic Alopecia | Phase 1 / Phase 2 | Unknown | Kasiak Research Pvt. Ltd. | 30 | 2012-01-01 | 2012-07-25 |
| The Efficacy in Treatment of Female Pattern Hair Loss Using 5% Minoxidil Solution Combinded With Zinc Supplement 15 mg Chelate zinc supplement, Placebo drug supplement - Female Pattern Alopecia | Phase 1 / Phase 2 | Unknown | Siriraj Hospital | 20 | 2012-01-01 | 2012-08-10 |
| Safety and Efficacy of Hair Stimulating Complex (HSC) on Hair Growth in Males With Androgenetic Alopecia Hair Stimulating Complex (HSC), Dulbecco's Modified Eagle Medium, DMEM - Androgenetic Alopecia | Phase 1 / Phase 2 | Unknown | Histogen | 56 | 2011-12-01 | 2012-01-18 |
| Efficacy Study of Tempol to Prevent Hair Loss From Radiotherapy to the Brain 7% (w/v) Tempol alcohol-based gel (MTS-01), alcohol-based gel - Alopecia | Phase 2 | Unknown | Mitos Pharmaceuticals | 16 | 2008-11-01 | 2008-12-03 |
| Dose-Ranging Efficacy Study of Topical NEOSH101 to Treat Male Pattern Hair Loss tetrapeptide aldehyde proteasome inhibitor (NEOSH101) - Androgenetic Alopecia | Phase 2 | Unknown | Neosil, Inc. | 140 | 2007-05-01 | 2008-05-20 |
| Topical AS101 for Treatment of FAGA (Female Androgenetic Alopecia) in Menopause Women AS101 - Alopecia | Phase 2 | Unknown | Rabin Medical Center | 40 | 2007-01-04 |
Alopecia Areata (8)
Hair Diseases (19) · Hypotrichosis (19) · Skin Diseases (19) · Skin and Connective Tissue Diseases (19) · Pathological Conditions, Anatomical (11) · Pathological Conditions, Signs and Symptoms (11)
Minoxidil (3) · Finasteride (2) · Vitamin D (2) · Ethanol (1) · Latanoprost (1) · Sodium Chloride (1) · Starch (1) · Triamcinolone Acetonide (1) · Zinc (1) · ammonium trichloro(dioxoethylene-O,O'-)tellurate (1) · calcipotriene (1) · tempol (1)
Kasiak Research Pvt. Ltd. (2) · ASLAN Pharmaceuticals (1) · Alexandria University (1) · AnaptysBio, Inc. (1) · Egymedicalpedia (1) · Histogen (1) · Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus (1) · Mitos Pharmaceuticals (1) · Neosil, Inc. (1) · Rabin Medical Center (1) · Siriraj Hospital (1) · Sohag University (1) · Suzhou Zelgen Biopharmaceuticals Co.,Ltd (1) · TetraLogic Pharmaceuticals (1) · Theradome, Inc. (1)
United States (4) · Egypt (3) · China (2) · India (2) · Canada (1) · Germany (1) · Indonesia (1) · Israel (1) · Philippines (1) · Thailand (1)
Rajendarsingh Rajput, Dr. (2) · Sandeep Sattur, Dr. (2) · Bruce Randazzo, MD (1) · Danny Ben-Amitai, M.D. (1) · Essam A Nada, MD (1) · Harvey Lui, MD FRCPC (1) · James Metz, MD (1) · Johannes Gassmueller, MD (1) · Julieta P. Arambulo, MD (1) · Soheir AbdelHamid Ali, Assist. Prof. (1) · Theresa Marie Reyes-Cacas, MD (1) · Yong Zhao, MD, PhD (1) · Zinaida Kvacheva (1)